SCHEMBL2769009

SCHEMBL2769009

Cc1ccc(NC(=O)N(S)c2noc3ccccc23)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.47
RAB9A P51151 5/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KIT P10721 1/20 0.46
KDR P35968 1/20 0.46
FLT3 P36888 1/20 0.46
HIF1A Q16665 4/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
THRB P10828 2/20 0.43
STING1 Q86WV6 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
POLB P06746 2/20 0.42
SMN1; SMN2 Q16637 5/20 0.41
LMNA P02545 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2769321 0.81 HIF1A (0.56) NPC1RAB9AHIF1AALDH1A1SMN1; SMN2
SCHEMBL2768548 0.80 MAPT (0.51) NPC1RAB9AHIF1AALDH1A1MAPT
SCHEMBL2768329 0.80 HIF1A (0.63) NPC1RAB9AL3MBTL1HIF1AALDH1A1
SCHEMBL2771191 0.79 SMN1; SMN2 (0.50) NPC1RAB9AKITKDRFLT3
SCHEMBL2772191 0.79 HIF1A (0.60) NPC1RAB9AHIF1AMAPTMEN1
SCHEMBL2768458 0.78 HCRTR1 (0.50) NPC1RAB9AHIF1AMAPTMEN1
SCHEMBL2770662 0.76 EPHX2 (0.52) NPC1RAB9AKITKDRHIF1A
SCHEMBL2769848 0.76 MAPT (0.61) HIF1AALDH1A1MAPTTHRBMEN1
SCHEMBL2768628 0.76 HIF1A (0.47) NPC1RAB9AHIF1AALDH1A1MAPT
SCHEMBL2770279 0.76 TP53 (0.51) RAB9AKITKDRFLT3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881967-B1 SUBSTITUTED BENZO(D)ISOXAZOL-3-YL AMINE COMPOUNDS AS ANALGESICS GRUENENTHAL GMBH (DE) 2010-04-28 EP claimed
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics GRUENENTHAL GMBH (DE) 2008-07-24 US claimed
US-7696238-B2 Substituted benzo[d]isoxazol-3-yl amine compounds as analgesics GRUENENTHAL GMBH (DE) 2010-04-13 US disclosed
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics GRUENENTHAL GMBH (DE) 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics KCNQ1, KCNQ2, KCNQ3 NPC1 2230/4885RAB9A 3127/4885L3MBTL1 1736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.